37 research outputs found
Structure and rheological properties of model microemulsion networks filled with nanoparticles
Model microemulsion networks of oil droplets stabilized by non ionic
surfactant and telechelic polymer C18-PEO(10k)-C18 have been studied for two
droplet-to-polymer size ratios. The rheological properties of the networks have
been measured as a function of network connectivity and can be described in
terms of simple percolation laws. The network structure has been characterised
by Small Angle Neutron Scattering. A Reverse Monte Carlo approach is used to
demonstrate the interplay of attraction and repulsion induced by the copolymer.
These model networks are then used as matrix for the incorporation of silica
nanoparticles (R=10nm), individual dispersion being checked by scattering. A
strong impact on the rheological properties is found for silica volume
fractions up to 9%
Individual and environmental determinants associated with longer times to access pediatric rheumatology centers for patients with juvenile idiopathic arthritis, a JIR cohort study.
Despite guidelines, poor access to appropriate care for juvenile idiopathic arthritis (JIA) patients remains a global issue. Prompt referral to a pediatric rheumatology (PR) center and effective care is known to be critical for changing the natural history of the disease and improving long-term prognosis. This project assesses socio-economic factors of delayed referral to a pediatric rheumatologist (PRst) for JIA patients in France and Switzerland within the Juvenile Inflammatory Rheumatism (JIR) Cohort.
All patients diagnosed with JIA, presenting at one center of the JIRcohort in France or Switzerland with additional data on referral pathway were included. Patient characteristics at first visit to the PR center, dates of visits to healthcare providers during referral, and parent characteristics were extracted from the JIRcohort database.
Two hundred fifty children were included. The overall median time to first PR assessment was 2.4 months [1.3; 6.9] and ranged widely across the JIA subtypes, from 1.4 months [0.6; 3.8] for children with systemic juvenile idiopathic arthritis (sJIA) to 5.3 months [2.0; 19.1] for children with enthesitis-related arthritis (ERA). A diagnosis of ERA and an appointment with an orthopedist during the referral pathway were significantly associated with a longer time before the first PR visit (hazard ratio HR 0.50 [95% CI: 0.29; 0.84]) and HR 0.68 [95% CI: 0.49; 0.93], respectively) in multivariable analysis. Having a mother with a post-graduate educational attainment level was tendentially associated with a shorter time before the first PR visit, (HR 1.32 [95% CI: 0.99; 1.78]).
Time to first PRst visit was most often short compared to other studies and close to the British recommendations. However, this time remained too long for many patients. We observed no social inequities in access to a PRst, but we show the need to improve effective pathway and access to a PR center for JIA patients
Creation of a cohort of French patients with chronic recurrent multifocal osteitis : preliminary results
Real-World Experience and Impact of Canakinumab in Cryopyrin-Associated Periodic Syndrome: Results From a French Observational Study
International audienceOBJECTIVE:The ENVOL study was designed to assess the psychosocial impact of disease and therapy in a French cohort of cryopyrin-associated periodic syndromes (CAPS) patients (and caregivers) treated with canakinumab.METHODS:The ENVOL study was a multicenter, observational study of CAPS patients given â„1 canakinumab dose. Data were collected before treatment, at 6 and 12 months afterward, and at the last visit. Patients and caregivers completed questionnaires assessing changes from the 12 months of pretreatment to 12 months prior to interview. Data were analyzed retrospectively.RESULTS:The study included 10 physicians and 68 patients (53 adults, 15 children). Sixty-five patients (95.6%) were still receiving canakinumab at the last visit (median 5 years after starting therapy). The meanâ±âSD score for patient-reported general health increased from 7â±â2.9 before canakinumab to 2.7â±â2.7 after treatment (Pâ40% of respondents. Caregivers spent a median of 3 versus 0.5 hours/week on care in the 12 months of pretreatment versus 12 months prior to interview (Pâ<â0.001). Following treatment, patients required fewer consultations with general practitioners (meanâ±âSD per patient per year: 5.2â±â7.4 versus 8.5â±â7.2 pretreatment), internists/rheumatologists/dermatologists (2.0â±â2.1 versus 3.7â±â3.9), and pediatricians (1.8â±â1.5 versus 4.4â±â4.2).CONCLUSION:Long-term treatment with canakinumab achieves a highly relevant improvement in the physical, emotional, and social lives of patients with CAPS, accompanied by a marked reduction in support required from caregivers and in health care consultations
âDaily life of CAPS patients treated with canakinumab (IlarisÂź) : data from the French observational study - ENVOL Studyâ
PReS-FINAL-2191: Imaging of chronic recurrent multifocal osteitis: a french national cohort of 178 cases
International audienc